Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 265

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Diabetic retinopathy screening: a systematic review of the economic evidence

Jones, S., Edwards, R. T.·2010·Diabetic Medicine

Abstract

Diabet. Med. 27, 249–256 (2010) This paper systematically reviews the published literature on the economic evidence of diabetic retinopathy screening. Twenty‐nine electronic databases were searched for studies published between 1998 and 2008. Internet searches were carried out and reference lists of key studies were hand searched for relevant articles. The key search terms used were ‘diabetic retinopathy’, ‘screening’, ‘economic’ and ‘cost’. The search identified 416 papers of which 21 fulfilled the inclusion criteria, comprising nine cost‐effectiveness studies, one cost analysis, one cost‐minimization analysis, four cost–utility analyses and six reviews. Eleven of the included studies used economic modelling techniques and/or computer simulation to assess screening strategies. To date, the economic evaluation literature on diabetic retinopathy screening has focused on four key questions: the overall cost‐effectiveness of ophthalmic care; the cost‐effectiveness of systematic vs. opportunistic screening; how screening should be organized and delivered; and how often people should be screened. Systematic screening for diabetic retinopathy is cost‐effective in terms of sight years preserved compared with no screening. Digital photography with telemedicine links has the potential to deliver cost‐effective, accessible screening to rural, remote and hard‐to‐reach populations. Variation in compliance rates, age of onset of diabetes, glycaemic control and screening sensitivities influence the cost‐effectiveness of screening programmes and are important sources of uncertainty in relation to the issue of optimal screening intervals. There is controversy in relation to the economic evidence on optimal screening intervals. Further research is needed to address the issue of optimal screening interval, the opportunities for targeted screening to reflect relative risk and the effect of different screening intervals on attendance or compliance by patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2009.02870.x

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 265

Metadata

Authors
Jones, S., & Edwards, R. T.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2010-03
Volume
27
Issue
3
Pages
249-256
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2142914838
Cited by
265
References
24
FWCI
1.08
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diabetic retinopathy screening: a systematic review of the economic evidence. https://app.cochat.ai/papers/10.1111/j.1464-5491.2009.02870.x
The paper
Jones, S., & Edwards, R. T. (2010). Diabetic retinopathy screening: a systematic review of the economic evidence. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2009.02870.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.